We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock

Delisted

GRNA was delisted on the 21st of July, 2023.

68 hedge funds and large institutions have $173M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

6% more capital invested

Capital invested by funds: $163M → $173M (+$9.8M)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

3% less funds holding

Funds holding: 7068 (-2)

Holders
68
Holders Change
-2
Holders Change %
-2.86%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
14
Reduced
11
Closed
15
Calls
$496K
Puts
Net Calls
+$496K
Net Calls Change
+$496K
Name Holding Trade Value Shares
Change
Change in
Stake
AIMCA
76
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$569K -57,500 Closed
KKRC
77
Kohlberg Kravis Roberts & Co
New York
-$508K -51,358 Closed
LCM
78
Landscape Capital Management
New Jersey
-$391K -39,538 Closed
MSU
79
Mizuho Securities USA
New York
-$244K -24,638 Closed
GCL
80
Glazer Capital LLC
New York
-$206K -20,791 Closed
Qube Research & Technologies (QRT)
81
Qube Research & Technologies (QRT)
United Kingdom
-$177K -17,857 Closed
VCM
82
Vivaldi Capital Management
Illinois
-$139K -14,023 Closed
JP Morgan Chase
83
JP Morgan Chase
New York
-$89K -8,988 Closed

GRNA Hedge Fund Activity: Q4 2021 in Review

68 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q4 2021, worth a combined $173M — up 6% from $163M a quarter earlier.

Fund positioning in GRNA was balanced in Q4 2021: 15 funds opened new positions, 15 closed out, 14 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $7.81M. The largest seller was Telemark Asset Management, exiting entirely with an estimated $5.93M sold.

  • 68 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q4 2021, down from 70 in Q3 2021.
  • Funds reported $173M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q4 2021, up 6% quarter-over-quarter.
  • 15 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q4 2021 and 15 closed out, a net change of 0 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q4 2021 was Marshall Wace, an estimated $7.81M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q4 2021 was Telemark Asset Management, an estimated $5.93M sold.

Based on aggregated 13F filings for Q4 2021.